UK's Spire Healthcare H1 hit by lower NHS activity, higher costs
Overview
UK healthcare provider's H1 revenue dipped 0.8% as NHS activity declined
Adjusted EBITDA for H1 fell 16.6%, reflecting cost inflation and lower NHS revenue
Adjusted free cash flow rose 35.3% on improved capital efficiency and lower capex
Outlook
Spire Healthcare continues to target FY26 adjusted EBITDA broadly in line with FY25
Company says demand for independent healthcare remains strong, with growth in private payor revenues
Spire Healthcare says visibility over NHS activity remains strong, with >95% of 2026/27 plan revenue agreed
Result Drivers
NHS REVENUE DECLINE - Lower NHS activity, especially a 24.9% drop in Q1, weighed on overall revenue and profitability
PRIVATE PAYOR GROWTH - Self-Pay and PMI revenues rose, supported by commercial initiatives and continued demand for private healthcare
COST INFLATION - Profitability was pressured by inflation across a largely fixed cost base, limiting the ability to offset NHS revenue shortfall
Company press release:
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
H1 Revenue | GBP 792.70 mln | ||
H1 Adjusted EBITDA | GBP 112.40 mln | ||
H1 Adjusted EBIT | GBP 50.60 mln | ||
H1 Adjusted Free Cash Flow | GBP 20.70 mln | ||
H1 Pretax Loss | GBP 14.80 mln |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Spire Healthcare Group PLC is GBp262.50, about 6.9% above its September 29 closing price of GBp245.50
The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 22 three months ago
Reuters Recommended Reads
Sept 29 - Close Brothers FY 2026 adjusted profit falls; not paying annual dividend
Sept 29 - Close Brothers profit beats expectations as restructuring progresses
Sept 28 - Can the UK forge a new era of reindustralisation?
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)